September 25, 2021
4 min watch
Save
VIDEO: Euretina best free paper award winner speaks on analysis of HAWK, HARRIER data
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video, Arshad Khanani, MD, speaks about a post hoc comparative assessment of patients treated with brolucizumab vs. aflibercept in the HAWK and HARRIER phase 3 studies.
For his presentation on this topic, Khanani received the best free paper award at the virtual Euretina congress.
Published by:
Sources/Disclosures
Collapse
Source:
Arshad Khanani, MD
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.